205 related articles for article (PubMed ID: 24204727)
21. Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels.
Gianulis EC; Trudeau MC
J Biol Chem; 2011 Jun; 286(25):22160-9. PubMed ID: 21536673
[TBL] [Abstract][Full Text] [Related]
22. Flavonoid regulation of EAG1 channels.
Carlson AE; Brelidze TI; Zagotta WN
J Gen Physiol; 2013 Mar; 141(3):347-58. PubMed ID: 23440277
[TBL] [Abstract][Full Text] [Related]
23. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
Mihic A; Chauhan VS; Gao X; Oudit GY; Tsushima RG
PLoS One; 2011 Mar; 6(3):e18273. PubMed ID: 21483829
[TBL] [Abstract][Full Text] [Related]
24. hERG potassium channel gating is mediated by N- and C-terminal region interactions.
Gustina AS; Trudeau MC
J Gen Physiol; 2011 Mar; 137(3):315-25. PubMed ID: 21357734
[TBL] [Abstract][Full Text] [Related]
25. The intrinsically liganded cyclic nucleotide-binding homology domain promotes KCNH channel activation.
Zhao Y; Goldschen-Ohm MP; Morais-Cabral JH; Chanda B; Robertson GA
J Gen Physiol; 2017 Feb; 149(2):249-260. PubMed ID: 28122815
[TBL] [Abstract][Full Text] [Related]
26. Role of intracellular domains in the function of the herg potassium channel.
Al-Owais M; Bracey K; Wray D
Eur Biophys J; 2009 Jun; 38(5):569-76. PubMed ID: 19172259
[TBL] [Abstract][Full Text] [Related]
27. Trafficking defects in PAS domain mutant Kv11.1 channels: roles of reduced domain stability and altered domain-domain interactions.
Ke Y; Ng CA; Hunter MJ; Mann SA; Heide J; Hill AP; Vandenberg JI
Biochem J; 2013 Aug; 454(1):69-77. PubMed ID: 23721480
[TBL] [Abstract][Full Text] [Related]
28. Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome.
Satler CA; Walsh EP; Vesely MR; Plummer MH; Ginsburg GS; Jacob HJ
Am J Med Genet; 1996 Oct; 65(1):27-35. PubMed ID: 8914737
[TBL] [Abstract][Full Text] [Related]
29. Identification of undecylenic acid as EAG channel inhibitor using surface plasmon resonance-based screen of KCNH channels.
Wang ZJ; Tiwari PB; Üren A; Brelidze TI
BMC Pharmacol Toxicol; 2019 Jul; 20(1):42. PubMed ID: 31315662
[TBL] [Abstract][Full Text] [Related]
30. hERG K(+) channels: structure, function, and clinical significance.
Vandenberg JI; Perry MD; Perrin MJ; Mann SA; Ke Y; Hill AP
Physiol Rev; 2012 Jul; 92(3):1393-478. PubMed ID: 22988594
[TBL] [Abstract][Full Text] [Related]
31. Chimeric hERG channels containing a tetramerization domain are functional and stable.
Hausammann GJ; Grütter MG
Biochemistry; 2013 Dec; 52(51):9237-45. PubMed ID: 24325597
[TBL] [Abstract][Full Text] [Related]
32. Investigation of PAS and CNBH domain interactions in hERG channels and effects of long-QT syndrome-causing mutations with surface plasmon resonance.
Soohoo SM; Tiwari PB; Suzuki YJ; Brelidze TI
J Biol Chem; 2022 Jan; 298(1):101433. PubMed ID: 34801551
[TBL] [Abstract][Full Text] [Related]
33. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation.
Chen J; Zou A; Splawski I; Keating MT; Sanguinetti MC
J Biol Chem; 1999 Apr; 274(15):10113-8. PubMed ID: 10187793
[TBL] [Abstract][Full Text] [Related]
34. Long QT2 mutation on the Kv11.1 ion channel inhibits current activity by ablating a protein kinase Cα consensus site.
Donovan AJ; Lansu K; Williams JG; Denning MF; Gentile S
Mol Pharmacol; 2012 Sep; 82(3):428-37. PubMed ID: 22653970
[TBL] [Abstract][Full Text] [Related]
35. (1)H, (13)C and (15)N chemical shift assignments for the cyclic-nucleotide binding homology domain of a KCNH channel.
Li Q; Ng HQ; Kang C
Biomol NMR Assign; 2015 Apr; 9(1):55-8. PubMed ID: 24414223
[TBL] [Abstract][Full Text] [Related]
36. The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote.
Hedley PL; Kanters JK; Dembic M; Jespersen T; Skibsbye L; Aidt FH; Eschen O; Graff C; Behr ER; Schlamowitz S; Corfield V; McKenna WJ; Christiansen M
Circ Cardiovasc Genet; 2013 Oct; 6(5):452-61. PubMed ID: 24021552
[TBL] [Abstract][Full Text] [Related]
37. The Eag domain regulates the voltage-dependent inactivation of rat Eag1 K+ channels.
Lin TF; Jow GM; Fang HY; Fu SJ; Wu HH; Chiu MM; Jeng CJ
PLoS One; 2014; 9(10):e110423. PubMed ID: 25333352
[TBL] [Abstract][Full Text] [Related]
38. Crystal structure of the PAS domain of the hEAG potassium channel.
Tang X; Shao J; Qin X
Acta Crystallogr F Struct Biol Commun; 2016 Aug; 72(Pt 8):578-85. PubMed ID: 27487920
[TBL] [Abstract][Full Text] [Related]
39. Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.
Perry M; Sachse FB; Sanguinetti MC
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13827-32. PubMed ID: 17693551
[TBL] [Abstract][Full Text] [Related]
40. Structure of KCNH2 cyclic nucleotide-binding homology domain reveals a functionally vital salt-bridge.
Ben-Bassat A; Giladi M; Haitin Y
J Gen Physiol; 2020 Apr; 152(4):. PubMed ID: 32191791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
